BioMendics advances its TAMES-02 trial of TolaSureâ„¢, a potential disease-modifying topical therapy for Epidermolysis Bullosa ...
Simplex Trading, a leading proprietary market-making firm, announced that it has been recognized by Built In as one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback